The Pan-American Health Organisation (PAHO) has stated that Venezuela has received its first batch of COVID-19 vaccines through the COVAX global vaccine facility intended for poor countries, Reuters news agency reported on Wednesday.
This comes after months of delays that the Venezuelan government attributed to US sanctions.
Venezuela has reportedly received 693,000 doses of Chinese biopharmaceutical company Sinovac Biotech Inc's (Nasdaq:SVA) COVID-19 vaccine, the first of a total of 11 million it will receive through COVAX, overseen by the GAVI alliance and the World Health Organisation.
So far, Venezuela has depended on Russia's Sputnik V COVID-19 vaccine and Chinese pharmaceutical company Sinopharm's shot to inoculate its population against COVID-19
An additional batch of Sputnik V COVID-19 doses has arrived this week in Venezuela, though authorities did not specify how many arrived.
According to PAHO estimates, about 3.3 million Venezuelans, or around 10% of the population, have been vaccinated.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
YS Biopharma repays USD40m loan facility
Kintara Therapeutics and TuHURA Biosciences to merge
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine